Literature DB >> 20121783

Mitigation of rocuronium-induced anaphylaxis by sugammadex: the great unknown.

P M Jones, T P Turkstra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20121783     DOI： 10.1111/j.1365-2044.2009.06177_1.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN： 0003-2409            Impact factor:   6.955


× No keyword cloud information.
  5 in total

1.  Can sugammadex encapsulation eliminate the antigenic activity of aminosteroidal neuromuscular blocking agent?

Authors:  Takashi Kawano; Masataka Yokoyama
Journal:  J Anesth       Date:  2011-09-09       Impact factor: 2.078

2.  Successful management of rocuronium-induced anaphylaxis with sugammadex: A case report.

Authors:  Sheng-Kai Hung; Chia-Chi Yeh; Pei-Chi Ting; Cay-Huyen Chen; Ming-Chang Kao
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

3.  In the hour of Sugammadex.

Authors:  Jin Young Chon
Journal:  Korean J Anesthesiol       Date:  2013-01-21

Review 4.  Sugammadex and rocuronium-induced anaphylaxis.

Authors:  Tomonori Takazawa; Hiromasa Mitsuhata; Paul Michel Mertes
Journal:  J Anesth       Date:  2015-12-08       Impact factor: 2.078

Review 5.  Advantages and pitfalls of clinical application of sugammadex.

Authors:  Hyung Young Lee; Ki Tae Jung
Journal:  Anesth Pain Med (Seoul)       Date:  2020-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.